EXO Biologics and its CDMO subsidiary, ExoXpert, innovators in exosome-based therapeutics and drug delivery solutions, has achieved a significant milestone with its subsidiary ExoXpert becoming the first European CDMO to receive Good Manufacturing Practice (GMP) certification. The certification, awarded by
ExoXpert, a Contract Development and Manufacturing Organisation (CDMO) specialising in exosome production, has announced a strategic partnership with Neucore Bio, a company at the forefront of non-viral engineered delivery technology. The partnership will utilise ExoXpert’s platform to evaluate advanced exosome
Exo Biologics, a Belgian biotech company, has announced the launch of ExoXpert, a new CDMO specialising in exosomes. This move comes as a response to the increasing global demand for exosomes, tiny vesicles that play a crucial role in cell-to-cell communication.
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
